ROCK1 is Associated with Alzheimer’s Disease-Specific Plaques, As Well As Enhances Autophagosome Formation but Not Autophagic Aβ Clearance

Yong-Bo Hu,Yang Zou,Yue Huang,Yong-Fang Zhang,Guinevere F. Lourenco,Sheng-Di Chen,Glenda M. Halliday,Gang Wang,Ru-Jing Ren
DOI: https://doi.org/10.3389/fncel.2016.00253
2016-01-01
Frontiers in Cellular Neuroscience
Abstract:Alzheimer’s disease (AD) is the most prevalent form of late-life dementia in the population, characterized by amyloid plaque formation and increased tau deposition, which is modulated by Rho-associated coiled-coil kinase 1 (ROCK1). In this study, we further analyze whether ROCK1 regulates the metabolism of amyloid precursor protein (APP). We show that ROCK1 is colocalized with mature amyloid-β (Aβ) plaques in patients with AD, in that ROCK1 enhances the amyloidogenic pathway, and that ROCK1 mediated autophagy enhances the intracellular buildup of Aβ in a cell model of AD (confirmed by increased ROCK1 and decreased Beclin 1 protein levels, with neuronal autophagosome accumulation in prefrontal cortex of AD APP/PS1 mouse model). In vitro over-expression of ROCK1 leads to a decrease in Aβ secretion and an increase in the expression of autophagy-related molecules. ROCK1 interacts with Beclin1, an autophagy initiator, and enhances the intracellular accumulation of Aβ. Reciprocally, overexpression of APP/Aβ promotes ROCK1 expression. Our data suggest ROCK1 participates in regulating Aβ secretion, APP shedding and autophagosome accumulation, and that ROCK1, rather than other kinases, is more likely to be a targetable enzyme for AD therapy.
What problem does this paper attempt to address?